** Brokerage Morgan Stanley starts coverage on hospital operator Tenet Healthcare THC.N with "overweight" rating and $165 PT
** New PT represents 26.2% upside to the stock's last close
** Brokerage says significant changes in business model and balance sheet not yet reflected in THC's stock price
** Brokerage believes co is well-positioned to benefit from the shift towards outpatient care as outpatient visits have grown ~30% from 2000 to 2022, driven by technological enhancements, reimbursement changes and consumer preferences
** Notes THC's key growth areas include orthopedics, urology, cardiology, GI and cancer
** Including session moves, THC stock up 4.5% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。